Free Trial

Salarius Pharmaceuticals (SLRX) Competitors

Salarius Pharmaceuticals logo
$4.60 +0.42 (+10.05%)
Closing price 04:00 PM Eastern
Extended Trading
$4.57 -0.03 (-0.65%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SLRX vs. PRTG, ALZN, OBSV, TTNP, MYNZ, BCDA, BCLI, KZIA, CDIO, and PPBT

Should you be buying Salarius Pharmaceuticals stock or one of its competitors? The main competitors of Salarius Pharmaceuticals include Portage Biotech (PRTG), Alzamend Neuro (ALZN), ObsEva (OBSV), Titan Pharmaceuticals (TTNP), Mainz Biomed (MYNZ), BioCardia (BCDA), Brainstorm Cell Therapeutics (BCLI), Novogen (KZIA), Cardio Diagnostics (CDIO), and Purple Biotech (PPBT). These companies are all part of the "pharmaceutical products" industry.

Salarius Pharmaceuticals vs. Its Competitors

Portage Biotech (NASDAQ:PRTG) and Salarius Pharmaceuticals (NASDAQ:SLRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

Portage Biotech's return on equity of 0.00% beat Salarius Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Portage BiotechN/A N/A N/A
Salarius Pharmaceuticals N/A -556.47%-192.35%

13.4% of Portage Biotech shares are held by institutional investors. Comparatively, 11.9% of Salarius Pharmaceuticals shares are held by institutional investors. 42.1% of Portage Biotech shares are held by insiders. Comparatively, 1.2% of Salarius Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Portage Biotech is trading at a lower price-to-earnings ratio than Salarius Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Portage BiotechN/AN/A-$6.77M-$41.65-0.18
Salarius PharmaceuticalsN/AN/A-$5.58M-$43.48-0.11

In the previous week, Salarius Pharmaceuticals had 4 more articles in the media than Portage Biotech. MarketBeat recorded 4 mentions for Salarius Pharmaceuticals and 0 mentions for Portage Biotech. Salarius Pharmaceuticals' average media sentiment score of 0.97 beat Portage Biotech's score of 0.00 indicating that Salarius Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Portage Biotech Neutral
Salarius Pharmaceuticals Positive

Portage Biotech has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, Salarius Pharmaceuticals has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.

Summary

Portage Biotech and Salarius Pharmaceuticals tied by winning 5 of the 10 factors compared between the two stocks.

Get Salarius Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLRX vs. The Competition

MetricSalarius PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.13M$2.96B$6.11B$10.46B
Dividend YieldN/A57.77%5.73%4.77%
P/E Ratio-0.1122.7985.3627.36
Price / SalesN/A756.67607.16135.99
Price / CashN/A172.6337.4661.86
Price / Book0.325.5112.426.81
Net Income-$5.58M$33.06M$3.32B$276.80M
7 Day Performance11.65%0.95%1.01%0.27%
1 Month Performance-15.60%14.25%10.75%8.31%
1 Year Performance-79.82%0.85%76.20%35.60%

Salarius Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLRX
Salarius Pharmaceuticals
0.8772 of 5 stars
$4.60
+10.0%
N/A-78.4%$2.13MN/A-0.1120
PRTG
Portage Biotech
N/A$7.63
+9.6%
N/A+3.2%$8.01MN/A-0.186Gap Up
High Trading Volume
ALZN
Alzamend Neuro
2.1575 of 5 stars
$2.54
-0.8%
$42.00
+1,553.5%
-85.2%$7.98MN/A0.004Analyst Forecast
OBSV
ObsEva
N/AN/AN/AN/A$7.94MN/A0.0050
TTNP
Titan Pharmaceuticals
0.7926 of 5 stars
$5.93
+23.7%
N/A+21.5%$7.88MN/A-2.0110Positive News
High Trading Volume
MYNZ
Mainz Biomed
2.682 of 5 stars
$1.72
+5.9%
$14.00
+716.3%
-88.0%$7.86M$890K-0.0330Negative News
Analyst Forecast
Gap Down
BCDA
BioCardia
3.479 of 5 stars
$1.35
-3.9%
$25.00
+1,758.7%
-40.2%$7.81MN/A-0.7340Gap Down
BCLI
Brainstorm Cell Therapeutics
1.1666 of 5 stars
$0.70
+1.4%
N/A-68.0%$7.72MN/A-0.2140Gap Down
KZIA
Novogen
3.4164 of 5 stars
$7.57
+11.7%
$16.50
+118.0%
-65.3%$7.62M$2.31M0.0012
CDIO
Cardio Diagnostics
0.8345 of 5 stars
$4.33
-1.7%
N/A-28.4%$7.61M$40K0.001
PPBT
Purple Biotech
1.7324 of 5 stars
$0.58
-4.8%
$33.00
+5,589.7%
-85.4%$7.45MN/A-1.3820Negative News

Related Companies and Tools


This page (NASDAQ:SLRX) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners